Sc1 Proteins of S pyogenes: Biology and Function

A组链球菌（GAS）是世界范围内人类死亡和发病的主要原因。因此，了解GAS定殖和侵入人类宿主的分子机制对于开发新的抗链球菌疗法非常重要。很明显，细胞表面GAS产物参与疾病。两个最近发现的链球菌基因，scl 1和scl 2，编码细胞表面蛋白，含有Gly-X-X胶原样重复。Scl的最后一个特征特别有趣，因为针对链球菌细胞壁抗原的抗体与人体组织抗原发生交叉反应，导致感染后自身免疫。然而，Scl蛋白在体内的表达和对宿主的抗原性尚不清楚。这项工作的长期目标是确定Scl在GAS粘附和侵袭人类细胞中的重要性，并评估抗SCL反应在人类自身免疫性疾病中的作用。本项目将检验以下假设：（a）Scl毒力因子有助于Gas发病，（B）scl基因的表达受各种控制机制的协调调节，许多GAS菌株同时产生Scl 1和Scl 2蛋白，（d）Scl蛋白在体内表达，感染宿主产生抗Scl特异性抗体。具体目的如下：首先，通过构建GAS菌株的基因定义的等基因scl 1和scl 2突变体并在小鼠感染模型中测试，确定Scl蛋白是否参与GAS引起的不同疾病类型的发病机制;其次，确定Scl蛋白是否有助于GAS粘附于人培养细胞和细胞外基质组分;第三，确定控制Scl基因表达的转录和翻译机制，以及GAS菌株是否同时产生两种Scl蛋白;第四，分析感染组织内Scl蛋白的表达以及人血清和实验模型中抗Scl特异性抗体的产生。这些研究将为抗链球菌治疗的发展提供新的方向，并且鉴于GAS表面上胶原样抗原Scl的存在，可能对人类自身免疫性疾病的未来研究具有重要意义。

Group A Streptococcus (GAS) is a major cause of human mortality and morbidity worldwide. Therefore, understanding the molecular mechanisms by which GAS colonizes and invades human hosts is important for the development of new anti-streptococcal therapies. It is clear that cell surface GAS products participate in disease. Two recently identified streptococcal genes, scl1 and scl2, encode cell surface proteins that contain Gly-X-X collagen-like repeats. This last characteristic of Scl is particularly intriguing due to the fact that antibodies against streptococcal cell-wall antigens cross-react with human-tissue antigens, resulting in post-infection autoimmunity. However, nothing is known about Scl protein expression in vivo and antigenicity for the host. The long-term objective of the proposed work is to determine the importance of Scl in GAS adherence to and invasion of human cells and to evaluate the role of anti-SCL response in human autoimmune diseases. This project will test the hypotheses that (a) Scl virulence factors contribute to Gas pathogenesis, (b) expression of scl genes is coordinately regulated by various control mechanisms and many GAS strains simultaneously produce both Scl1 and Scl2 proteins, and (d) Scl proteins are expressed in vivo and anti-Scl-specific antibodies are produced by the infected host. The specific aims are as follows: First, determine whether Scl proteins participate in the pathogenesis of different disease types caused by GAS by constructing genetically defined isogenic scl1 and scl2 mutants of GAS strains and testing them in mouse infection models; second, determine whether Scl proteins contribute to GAS adherence to human cultered cells and extracellular matrix components; third, determine transcriptional and translational mechanisms controlling scl gene expression and whether GAS strains simultaneously produce both Scl proteins; and fourth, analyze expression of Scl proteins within infected tissue and production of anti-Scl-specific antibodies in human sera and in experimental models. The proposed studies will provide new directions for the development of anti-streptococcal therapies and, in light of the existence of the collagen- like antigen Scl on the surface of GAS, may have important implications for future studies of human autoimmune diseases.